Daily market insights on Telegram
Share Predictions

Stocks

Stock predictionsToday's rankings and AI sentiment SectorsWhere each part of the market leans Stock directoryEvery U.S. stock, A to Z AI trading portfolioA simulation of the predictions Penny stocks portfolioA simulation, for penny stocks

Options

Options chainCalls and puts for any U.S. stock Options predictionsEvery closed one, wins and losses Options directoryEvery optionable stock, A to Z Options guidesFrom Greeks to spreads, in plain words

Apps

SharePredsStocks OpPredsOptions CPredsCrypto TradeSimSimulator Average CostCalculator All apps

Tools

All trading tools Get SharePreds

Glaukos Corporation (GKOS) stock analysis and AI prediction

The company facts of Glaukos Corporation, with its price and AI prediction for the next 10 market days in SharePreds.

Keep looking in SharePreds

You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.

QR code that opens SharePreds in your phone's app storeScan with your phone
See all five apps
SharePreds ranking U.S. stocks by their chance of rising over the next 10 days

About Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Exchange
NYSE
Market value
$14.6 billion
Employees
1,094
Headquarters
ALISO VIEJO, CA
Listed since
June 25, 2015

GKOS questions

What is the AI prediction for GKOS stock?

Each market day our model rates Glaukos Corporation (GKOS) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.

How often is the GKOS prediction updated?

Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.

What do Bullish, Neutral and Bearish mean?

Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.

Where can I see the exact likelihood for GKOS?

In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.

Where can I see GKOS options?

The GKOS options page opens its calls and puts, with price, volume, implied volatility and the Greeks.